Patent ID: 11911473
Assignee: AZURITY PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 1:
2. The method of claim 1, wherein the liquid diluent consisting essentially of:
1.0%-4.0% w/v of the poloxamer, wherein the poloxamer is poloxamer 188;
1.0%-2.0% w/v of sodium carboxymethylcellulose (CMC);
8.0%-8.8% w/v of sodium bicarbonate;
0.5%-1.5% w/v of the buffering agent, wherein the buffering agent is sodium citrate;
0.1%-0.3% w/v of simethicone emulsion;
0.35%-3.5% w/v of the sweetener;
0.4%-0.6% w/v of the preservative; and
water;
wherein the liquid diluent is stable for at least 30 days at 5±3° C. and is resistant to gel formation for at least one freeze-thaw cycle.